Jürgen Dinger

No ORCID on file · 4 papers in corpus
article 2017
Cardiovascular safety among users of different combined oral contraceptives — final results from the INAS-SCORE study
·doi:10.1016/j.contraception.2017.07.114
article 2016
Impact of estrogen type on cardiovascular safety of combined oral contraceptives
·doi:10.1016/j.contraception.2016.06.010

ObjectivesThe International Active Surveillance study "Safety of Contraceptives: Role of Estrogens" (INAS-SCORE) investigated the cardiovascular risks associated with the use of a combined oral contraceptive (COC) containing dienogest and e…

article 2010
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study
·doi:10.1783/147118910791749416

OBJECTIVE: The primary objective of the study was to clarify whether the use of the oral contraceptive 2 mg dienogest/30 microg ethinylestradiol (DNG/EE) is associated with a higher risk of venous thromboembolism (VTE) than the use of other…

article 2009
P750 Risk of venous thromboembolism and use of dienogest‐containing oral contraceptives – results from a case–control study
·doi:10.1016/s0020-7292(09)62241-4